Shanghai Huayi (SH:600623) Orient Securities·2025-06-02 10:23Investment Rating - The report assigns a "Buy" rating for the company, with a target price of 8.60 CNY based on a 20x PE ratio for 2025 [2][6]. Core Views - The company is expected to achieve steady growth in profitability due to the full production of the Guangxi base, falling coal prices, and recovery in industry conditions. Earnings per share are projected to be 0.43 CNY in 2025 and 0.60 CNY in 2026 and 2027 [2][12]. - The Guangxi integrated base is anticipated to significantly enhance the company's competitiveness and profitability stability upon full operation, marking a new development phase for the company [9][39]. - The company is initiating a second round of asset securitization, with plans to acquire a 60% stake in San Aifu, which is expected to lead to the injection of high-quality chemical assets into the listed company [13][49]. Summary by Sections Company Overview - The company has a long history and has evolved into a large chemical group with operations in coal chemical, carbon three, tires, and chemical services across multiple bases in China and Thailand [12][32]. Guangxi Base Development - The Guangxi integrated base, covering approximately 8,000 acres with a total planned investment of about 90 billion CNY, is divided into three phases, with the first two phases already operational and the third phase expected to be completed by the end of 2025 [39][40]. - The base will enable the company to achieve a high level of integration across its coal chemical, carbon three, and chlor-alkali businesses, enhancing overall competitiveness [39][41]. Financial Projections - Revenue is projected to grow from 40.86 billion CNY in 2023 to 47.97 billion CNY in 2027, with a slight decline in 2025 due to market conditions [4]. - The net profit attributable to the parent company is expected to increase from 861 million CNY in 2023 to 1.28 billion CNY in 2026, reflecting a recovery in profitability [4]. Market Position and Valuation - The company has been undervalued with a long-term price-to-book ratio below 1, but the upcoming asset injections and improved market conditions are expected to drive a valuation recovery [9][49]. - The company’s strategic location in Guangxi provides significant advantages in terms of logistics and market access, particularly to the rapidly growing markets in Southeast Asia and South China [45][46].